Identification of Poor Risk Patients in Low and Intermediate-1 (Int-1) IPSS MDS with the New Ipssr Index and Comparison with Other Prognostic Indexes. A Study by the Spanish Group of MDS (GESMD)

被引：1

作者：

Valcarcel, David ^{[1
]}

Sanz, Guillermo ^{[2
]}

Ortega, Margarita ^{[3
]}

Nomdedeu, Benet ^{[4
]}

Luno, Elisa ^{[5
]}

Diez-Campelo, Maria ^{[6
]}

Teresa Ardanaz, M. ^{[7
]}

Pedro, Carmen ^{[8
]}

Montoro, Julia ^{[1
]}

Collado, Rosa ^{[9
]}

Andreu, Rafa ^{[10
]}

Marco, Victor ^{[11
]}

Teresa Cedena, Maria ^{[12
]}

de Paz, Raquel ^{[13
]}

Tormo, Mar ^{[14
]}

Xicoy, Blanca ^{[15
]}

Ramos, Fernando ^{[16
]}

Bargay, Joan ^{[17
]}

Gonzalez, Bernardo ^{[18
]}

Brunet, Salut ^{[19
]}

Antonio Muaoz, Juan ^{[20
]}

Gomez, Valle ^{[21
]}

Bailen, Alicia ^{[22
]}

Sanchez', Joaquin ^{[23
]}

Vallespi, Teresa ^{[3
]}

机构：

[1] Hosp Valle De Hebron, Barcelona, Spain

[2] Hosp Univ La Fe, Dept Hematol, Valencia, Spain

[3] Hosp Univ Vall dHebron, Unidad Citogenet Hematol, Barcelona, Spain

[4] Hosp Clin Barcelona, Barcelona, Spain

[5] Cent Asturias, Hosp U, Hematol, Oviedo, Spain

[6] Hosp Univ Salamanca, Salamanca, Spain

[7] H Txagorritxu, Hematol, Vitoria, Spain

[8] Hosp del Mar, Barcelona, Spain

[9] Hosp Gen Univ Valencia, Hematol Serv, Biomed Diag Ctr, Valencia, Spain

[10] Hosp Univ Dr Peset, Valencia, Spain

[11] Hosp Arnau da Vilanova, Lleida, Spain

[12] H 12 Octubre, Madrid, Spain

[13] Hosp Univ La Paz, Madrid, Spain

[14] Hosp Clin, Valencia, Spain

[15] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, IJC ICO Badalona, Badalona, Spain

[16] Hosp Leon, Leon, Spain

[17] Hosp Sont Llatzer, Palma De Mallorca, Spain

[18] H Univ Canarias, Tenerife, Spain

[19] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[20] H Univ Puerta del Mar, Cadiz, Spain

[21] H Univ La Princesa, Madrid, Spain

[22] Hosp Carlos Haya, Malaga, Spain

[23] H Reina Sofia, Cordoba, Spain

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.702.702

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

702

引用

页数：3

共 50 条

[1] Acquisition of Cytogenetic Abnormalities (CA) Is a Very Poor Prognostic Feature in Patients (pts) with Low and Intermediate-1 (int-1) Risk Myelodysplastic Syndromes (MDS)
Jabbour, Elias
Kantarjian, Hagop M.
Wang, Xuemei
Abruzzo, Lynne V.
Cornelison, A. Megan
O'Brien, Susan
Ravandi, Farhad
Kadia, Tapan
Borthakur, Gautam
Estrov, Zeev
Cortes, Jorge E.
Garcia-Manero, Guillermo
[J]. BLOOD, 2011, 118 (21) : 1624 - 1624
[2] An Integrated Analysis of Darbepoetin Alfa (DAR) in the Treatment of Anemia in Patients with Low- or Intermediate-1 (int-1) Risk Myelodysplastic Syndrome (MDS)
Platzbecker, Uwe
Symeonidis, Argiris
Goede, Jeroen Simon
Guerci-Bresler, Agnes
Delforge, Michel
Oliva, Esther Natalie
Mayer, Jiri
Badre, Sejal
Mehta, Bhakti
Brandao, Cisio De Oliveira
[J]. BLOOD, 2017, 130
[3] IMPACT OF MDS ON HEALTH-RELATED QUALITY OF LIFE: A COMPARISON OF IPSS LOW-AND INT-1 RISK MDS PATIENTS FROM THE EUROPEAN LEUKEMIANET MDS (EUMDS) REGISTRY AND EUROPEAN REFERENCE POPULATIONS
Stauder, R.
Bagguley, T.
Smith, A.
Fenaux, P.
Symeonidis, A.
Cermak, J.
Sanz, G.
Hellstrom-Lindberg, E.
Mittelman, M.
Malcovati, L.
Huls, G.
Madry, K.
Germing, U.
Tatic, A.
Holm, M. S.
Savic, A.
Droste, J.
Guerci-Bresler, A.
Slama, B.
Luno, E.
Culligan, D.
de Swart, L.
Johnston, W. T.
Bowen, D.
de Witte, T.
[J]. HAEMATOLOGICA, 2015, 100 : 68 - 69
[4] Validation Of The Revised International Prognostic Scoring System (IPSS-R) In 1000 Newly Diagnosed MDS Patients With Low- and Intermediate-1 Risk MDS In The European Leukemianet MDS (EUMDS) Registry
de Swart, Louise
Smith, Alex
Johnston, Tom
Haase, Detlef
Droste, Jackie
Fenaux, Pierre
Symeonidis, Argiris
Sanz, Guillermo
Hellstroem-Lindberg, Eva
Cermak, Jaroslav
Germing, Ulrich
Stauder, Reinhard
Georgescu, Otilia
MacKenzie, Marius
Malcovati, Luca
Holm, Mette Skov
Almeida, Antonio Medina
Madry, Krzysztof
Slama, Borhane
Guerci-Bresler, Agnes
Sanhes, Laurence
Beyne-Rauzy, Odile
Luno, Elisa
Bowen, David
de Witte, Theo
[J]. BLOOD, 2013, 122 (21)
[5] Phase II Study of Targeted Subcutaneous (SC) Bortezomib for Patients with Low- or Intermediate-1 (Int-1)-Risk Myelodysplastic Syndrome (MDS) with Evidence of NF-κB Activation
Randhawa, Jasleen K.
Jabbar, Kausar Jabeen
Kadia, Tapan
Borthakur, Gautam
Pemmaraju, Naveen
Daver, Naval
Kantarjian, Hagop M.
Cortes, Jorge E.
Hearn, Katherine
Bueso-Ramos, Carlos E.
Garcia-Manero, Guillermo
[J]. BLOOD, 2014, 124 (21)
[6] Cytogenetic Evolution in Patients with IPSS Low and Intermediate-1 Risk. Study from the Spanish Group of Myelodysplastic Syndrome
Marcel Merchan, Brayan
Ortega, Margarita
Jose Llamas-Poyato, Mara
Cortes, Montserrat
Arnan, Montserrat
Cervero, Carlos
Montoro, Julia
Gimenez, Teresa
Lopez, Mara
Arenillas, Leonor
Valcarcel, David
[J]. BLOOD, 2014, 124 (21)
[7] Updated Phase II Study of Targeted Subcutaneous (SC) Bortezomib for Patients with Low- or Intermediate-1 (Int-1)-Risk Myelodysplastic Syndrome (MDS) with Evidence of NF-κb Activation
Daher, May
Lopez, Juliana Elisa Hidalgo
Randhawa, Jasleen K.
Jabbar, Kausar Jabeen
Pemmaraju, Naveen
Borthakur, Gautam
Kadia, Tapan M.
Konopleva, Marina
Kantarjian, Hagop M.
Cortes, Jorge E.
Hearn, Katherine P.
Reyes, Steven R.
Bueso-Ramos, Carlos E.
Garcia-Manero, Guillermo
[J]. BLOOD, 2016, 128 (22)
[8] A PHASE 3 RANDOMIZED PLACEBO (PBO)-CONTROLLED DOUBLE-BLIND TRIAL OF DARBEPOETIN ALFA IN LOW OR INTERMEDIATE-1 (INT-1) RISK MYELODYSPLASTIC SYNDROMES (MDS)
Platzbecker, U.
Symeonidis, A.
Oliva, E.
Goede, J.
Delforge, M.
Mayer, J.
Slama, B.
Badre, S.
Gasal, E.
Mehta, B.
Franklin, J.
[J]. HAEMATOLOGICA, 2017, 102 : 484 - 484
[9] A PHASE 3 RANDOMIZED PLACEBO (PBO)-CONTROLLED DOUBLE-BLIND TRIAL OF DARBEPOETIN ALFA IN LOW OR INTERMEDIATE-1 (INT-1) RISK MYELODYSPLASTIC SYNDROMES (MDS)
Platzbecker, U.
Symeonidis, A.
Oliva, E.
Goede, J.
Delforge, M.
Mayer, J.
Slama, B.
Badre, S.
Gasal, E.
Mehta, B.
Franklin, J.
[J]. LEUKEMIA RESEARCH, 2017, 55 : S29 - S30
[10] ACQUISITION OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH IPSS LOW AND INTERMEDIATE-1 RISK. STUDY FROM THE SPANISH GROUP OF MYELODYSPLASTIC SYNDROME
Merchan, B.
Ortega, M.
Llamas-Poyato, M. J.
Cortes, M.
Arnan, M.
Cervero, C.
Montoro, J.
Gimenez, T.
Lopez, M.
Arenillas, L.
Valcarcel, D.
[J]. LEUKEMIA RESEARCH, 2015, 39 : S136 - S136

← 1 2 3 4 5 →